Home › Funds › Bruce & Co., Inc. › BBNX

Bruce & Co., Inc. position in BBNX

BETA BIONICS INC · Health Care

Bruce & Co., Inc. reported holding 665,700 shares of BBNX (BETA BIONICS INC) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 2.82% of its reported portfolio and ranking #13 among its reported holdings. Bruce & Co., Inc. has disclosed BBNX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)665.70K sh
Reported value held$10.43M
Portfolio Weight2.82%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bruce & Co., Inc.'s BBNX position evolved

Bruce & Co., Inc. first disclosed a stake in BBNX in Q1 2026 at 550,700 shares (US$5.5M). The position peaked in Q2 2026 at 665,700 shares, worth US$10.4M. Across 2 filings, Bruce & Co., Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 665,700 shares valued at US$10.4M — an increase of 115,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 550.70K $5.52M New
Q2 2026 665.70K $10.43M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBNX and 13F data

BBNX (BETA BIONICS INC) is a Health Care company. 52 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$98.1M), Soleus Capital Management, L.P. (US$68.8M), Sands Capital Alternatives, LLC (US$58.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBNX

All BBNX fund holders →

FAQ

How long has Bruce & Co., Inc. held BBNX?

Bruce & Co., Inc. has disclosed BBNX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Bruce & Co., Inc.'s current position in BBNX?

As of Q2 2026, Bruce & Co., Inc. holds 665.70K shares of BBNX (BETA BIONICS INC), valued at $10.43M, representing 2.82% of its reported portfolio and ranking #13.

Has Bruce & Co., Inc. been buying or selling BBNX?

In the latest 13F filing (Q2 2026), Bruce & Co., Inc. increased its position in BBNX. The position peaked in Q2 2026 at 665.70K shares.

Which other funds hold BBNX?

Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.